PPT-Overview of ALS Genetics

Parts of whats known and a glimpse of whats next Patrick Dion PhD Neurology and Neurosurgery McGill University Human Genome Basics 3 billions base pairs Contains proteincoding and noncoding DNA. Presented by Alexia DeLara, Vanesa Mesic, . Joseph Ekofo, Amber . Tinagero, . and Jerilyn Curtis. What is ALS?. ALS is a rapidly progressive idiopathic neurodegenerative disease primarily targeting voluntary motor neurons, which may result in muscle weakness, paralysis, and respiratory failure. 2013-2014 Report. Jeff . Bennetzen. , Chair. Origins of MGEC. Role of MGEC. …to . identify both the needs and the opportunities for maize genetics, and to communicate this information to the broadest possible life science community. By: Keith King. Objectives. State the history of genetics;. Describe major century events;. Define terms used in genetics . History of Genetics. People have known about inheritance for a long time.. --children resemble their parents. March 2014. ALS Group. ALS has an enviable reputation for delivering a quality . service . which includes accurate and timely data, expert support and a culture of safety and innovation. We employ over 11,000 staff worldwide. We operate more than 300 laboratories in over 50 countries across Africa, Asia, Australia, Europe, North America and South America.. http://www.dnapolicy.org/. “A . treatable . disease . like . severe asthma”. “Having a bad . reaction to . certain types of medicine”. No. Yes. “An . untreatable . disease . like . Alzheimer’s”. Susana Reyes . Accelerator Safety and Configuration Control Engineer . Presented at the 2017 DOE Accelerator Safety Workshop. August 16, 2017. Outline. Intro. ALS-U RSS status. Conceptual design approach. ALS Research Counts on You. Division of Toxicology and Human Health Sciences. Environmental Health Surveillance Branch. Paul Mehta, MD. Principal Investigator. National ALS Registry. www.cdc.gov/als. Merit E. Cudkowicz, MD, MSc. Mass General Hospital. Founding Co-Chair, Northeast ALS Consortium. ALS Clinical Therapeutic Pipeline. Remarkable Successes in ALS. Three FDA approved treatments. Riluzole. OT 510/515. Rachel . Rombalski. Amy . Londry. Rachel . Csatari. Alyssa . Kolanowski. . Introduction. Brief overview of ALS. Stages of ALS. Case Study: . Roberto. Areas of Occupation . Affected. Role of Occupational Therapy in Treating . International Alliance of ALS/MND Associations . 4 October 2019. One of the strategic goals of the International Alliance of ALS/MND Associations (IAAA) is to promote and support scientific research for the cause, avoidance, cure and treatment of ALS. der gesundheitlichen Versorgung. 26. Kleinwuchsforum. 14.-17. Mai 2015 in . Hohenroda. Christopher . Kofahl. Universitätsklinikum Hamburg Eppendorf. Institut für Medizinische Soziologie. Martinistr. 52. Paper ID: 8762. K. M. Naimul Hassan. , Md. Shamiul . Alam. . Hridoy. , Naima Tasnim, . Atia. . Faria. Chowdhury, Tanvir . Alam. Roni, Sheikh Tabrez, Arik . Subhana. , Celia Shahnaz. Department of Electrical and Electronic Engineering (EEE),. Significance and Impact. The work lays out a basic strategy for engineering the band structures of semimetallic compounds using dimensional confinement and reveals a new way of creating two-dimensional electron/hole gases by exploiting interfacial bonding.. An Operational Perspective. Topics. Covered. History. . Delivery Models. Staffing Models. EMS System Design – Clinical vs. Economic. Operational Impacts. Cost Impacts. Controversies. Conclusions.